153 related articles for article (PubMed ID: 34967262)
1. Biodegradable hollow mesoporous organosilica nanotheranostics (HMONs) as a versatile platform for multimodal imaging and phototherapeutic-triggered endolysosomal disruption in ovarian cancer.
Li P; Lin B; Chen Z; Liu P; Liu J; Li W; Liu P; Guo Z; Chen C
Drug Deliv; 2022 Dec; 29(1):161-173. PubMed ID: 34967262
[TBL] [Abstract][Full Text] [Related]
2. Biodegradable hollow mesoporous organosilica nanotheranostics (HMON) for multi-mode imaging and mild photo-therapeutic-induced mitochondrial damage on gastric cancer.
Guo W; Chen Z; Chen J; Feng X; Yang Y; Huang H; Liang Y; Shen G; Liang Y; Peng C; Li Y; Li G; Huang W; Zhao B; Hu Y
J Nanobiotechnology; 2020 Jul; 18(1):99. PubMed ID: 32690085
[TBL] [Abstract][Full Text] [Related]
3. Merging metal organic framework with hollow organosilica nanoparticles as a versatile nanoplatform for cancer theranostics.
Chen L; Zhang J; Zhou X; Yang S; Zhang Q; Wang W; You Z; Peng C; He C
Acta Biomater; 2019 Mar; 86():406-415. PubMed ID: 30625415
[TBL] [Abstract][Full Text] [Related]
4. Chemodrug-Gated Biodegradable Hollow Mesoporous Organosilica Nanotheranostics for Multimodal Imaging-Guided Low-Temperature Photothermal Therapy/Chemotherapy of Cancer.
Wu J; Bremner DH; Niu S; Shi M; Wang H; Tang R; Zhu LM
ACS Appl Mater Interfaces; 2018 Dec; 10(49):42115-42126. PubMed ID: 30462492
[TBL] [Abstract][Full Text] [Related]
5. Interface-Engineered Paclitaxel-Based Hollow Mesoporous Organosilica Nanoplatforms for Photothermal-Enhanced Chemotherapy of Tumor.
Qian C; Al-Hamyari B; Tang X; Hou B; Yang S; Zhang G; Lv H; Yang Z; Wang Z; Shi Y
Mol Pharm; 2021 Dec; 18(12):4531-4542. PubMed ID: 34739255
[TBL] [Abstract][Full Text] [Related]
6. Acidity/Reducibility Dual-Responsive Hollow Mesoporous Organosilica Nanoplatforms for Tumor-Specific Self-Assembly and Synergistic Therapy.
Tang W; Fan W; Wang Z; Zhang W; Zhou S; Liu Y; Yang Z; Shao E; Zhang G; Jacobson O; Shan L; Tian R; Cheng S; Lin L; Dai Y; Shen Z; Niu G; Xie J; Chen X
ACS Nano; 2018 Dec; 12(12):12269-12283. PubMed ID: 30418749
[TBL] [Abstract][Full Text] [Related]
7. Dendrimer-encapsulated naphthalocyanine as a single agent-based theranostic nanoplatform for near-infrared fluorescence imaging and combinatorial anticancer phototherapy.
Taratula O; Schumann C; Duong T; Taylor KL; Taratula O
Nanoscale; 2015 Mar; 7(9):3888-902. PubMed ID: 25422147
[TBL] [Abstract][Full Text] [Related]
8. Photo-responsive degradable hollow mesoporous organosilica nanoplatforms for drug delivery.
Fan J; Zhang Z; Wang Y; Lin S; Yang S
J Nanobiotechnology; 2020 Jun; 18(1):91. PubMed ID: 32539777
[TBL] [Abstract][Full Text] [Related]
9. A Tumor-Activatable Theranostic Nanomedicine Platform for NIR Fluorescence-Guided Surgery and Combinatorial Phototherapy.
Li X; Schumann C; Albarqi HA; Lee CJ; Alani AWG; Bracha S; Milovancev M; Taratula O; Taratula O
Theranostics; 2018; 8(3):767-784. PubMed ID: 29344305
[TBL] [Abstract][Full Text] [Related]
10. Development of FL/MR dual-modal Au nanobipyramids for targeted cancer imaging and photothermal therapy.
Wang Y; Li M; Luo T; Jiao M; Jin S; Dou P; Zuo F; Wu C; Han C; Li J; Xu K; Zheng S
Mater Sci Eng C Mater Biol Appl; 2021 Aug; 127():112190. PubMed ID: 34225846
[TBL] [Abstract][Full Text] [Related]
11. Intelligent Pore Switch of Hollow Mesoporous Organosilica Nanoparticles for High Contrast Magnetic Resonance Imaging and Tumor-Specific Chemotherapy.
Huang L; Feng J; Fan W; Tang W; Rong X; Liao W; Wei Z; Xu Y; Wu A; Chen X; Shen Z
Nano Lett; 2021 Nov; 21(22):9551-9559. PubMed ID: 34738816
[TBL] [Abstract][Full Text] [Related]
12. Smart Cancer Cell Targeting Imaging and Drug Delivery System by Systematically Engineering Periodic Mesoporous Organosilica Nanoparticles.
Lu N; Tian Y; Tian W; Huang P; Liu Y; Tang Y; Wang C; Wang S; Su Y; Zhang Y; Pan J; Teng Z; Lu G
ACS Appl Mater Interfaces; 2016 Feb; 8(5):2985-93. PubMed ID: 26767305
[TBL] [Abstract][Full Text] [Related]
13. A Tumor Microenvironment-Responsive Biodegradable Mesoporous Nanosystem for Anti-Inflammation and Cancer Theranostics.
Wu J; Niu S; Bremner DH; Nie W; Fu Z; Li D; Zhu LM
Adv Healthc Mater; 2020 Jan; 9(2):e1901307. PubMed ID: 31814332
[TBL] [Abstract][Full Text] [Related]
14. Biodegradable Hollow Mesoporous Organosilica Nanotheranostics for Mild Hyperthermia-Induced Bubble-Enhanced Oxygen-Sensitized Radiotherapy.
Lu N; Fan W; Yi X; Wang S; Wang Z; Tian R; Jacobson O; Liu Y; Yung BC; Zhang G; Teng Z; Yang K; Zhang M; Niu G; Lu G; Chen X
ACS Nano; 2018 Feb; 12(2):1580-1591. PubMed ID: 29384652
[TBL] [Abstract][Full Text] [Related]
15. Co-delivery of nanoparticle and molecular drug by hollow mesoporous organosilica for tumor-activated and photothermal-augmented chemotherapy of breast cancer.
Zhang H; Song F; Dong C; Yu L; Chang C; Chen Y
J Nanobiotechnology; 2021 Sep; 19(1):290. PubMed ID: 34579711
[TBL] [Abstract][Full Text] [Related]
16. Gold-Nanobipyramid-Based Nanotheranostics for Dual-Modality Imaging-Guided Phototherapy.
Li C; Mei E; Chen C; Li Y; Nugasur B; Hou L; Ding X; Hu M; Zhang Y; Su Z; Lin J; Yang Y; Huang P; Li Z
ACS Appl Mater Interfaces; 2020 Mar; 12(11):12541-12548. PubMed ID: 32083461
[TBL] [Abstract][Full Text] [Related]
17. Glutathione-Mediated Clearable Nanoparticles Based on Ultrasmall Gd
Cheng Y; Lu T; Wang Y; Song Y; Wang S; Lu Q; Yang L; Tan F; Li J; Li N
Mol Pharm; 2019 Aug; 16(8):3489-3501. PubMed ID: 31246475
[TBL] [Abstract][Full Text] [Related]
18. Hollow Mesoporous Silica Nanoparticles Gated by Chitosan-Copper Sulfide Composites as Theranostic Agents for the Treatment of Breast Cancer.
Niu S; Zhang X; Williams GR; Wu J; Gao F; Fu Z; Chen X; Lu S; Zhu LM
Acta Biomater; 2021 May; 126():408-420. PubMed ID: 33731303
[TBL] [Abstract][Full Text] [Related]
19. Near Infrared-Triggered Theranostic Nanoplatform with Controlled Release of HSP90 Inhibitor for Synergistic Mild Photothermal and Enhanced Nanocatalytic Therapy with Hypoxia Relief.
Tian B; Wang C; Du Y; Dong S; Feng L; Liu B; Liu S; Ding H; Gai S; He F; Yang P
Small; 2022 Jul; 18(28):e2200786. PubMed ID: 35661402
[TBL] [Abstract][Full Text] [Related]
20. Dual-Stimuli Responsive Nanotheranostics for Multimodal Imaging Guided Trimodal Synergistic Therapy.
Fang S; Lin J; Li C; Huang P; Hou W; Zhang C; Liu J; Huang S; Luo Y; Fan W; Cui D; Xu Y; Li Z
Small; 2017 Feb; 13(6):. PubMed ID: 27862953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
